LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT By and Between MIDATECH PHARMA PLC And CMS Bridging Limited And CMS Medical Hong Kong Limited And China Medical System Holdings Limited LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENTLicense, Collaboration and Distribution Agreement • May 28th, 2019 • Midatech Pharma PLC • Pharmaceutical preparations • England
This License, Collaboration and Distribution Agreement (the “Agreement”) is entered into as of 29 January 2019 (the “Effective Date”) by and between Midatech Pharma PLC, a company organized and existing under the laws of England and Wales, with registration number 09216368), whose registered office is at 65 Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire OX14 4RQ (“Licensor”) and CMS Bridging Limited, a company organized and existing under the laws of Hong Kong, Unit 2106, 21/F, Island Place Tower, No. 510 King’s Road, North Point, Hong Kong (“CMS Bridging”), CMS Medical Hong Kong Limited , a company organized and existing under the laws of Hong Kong, Unit 2106, 21/F, Island Place Tower, No. 510 King’s Road, North Point, Hong Kong (“CMS HK”), and China Medical System Holdings Limited, a company organized and existing under the laws of the Cayman Islands with registration number MC-179153 and having its registered office at Maples Corporate Services Limited, PO Box 309, Ugl
ContractLicense, Collaboration and Distribution Agreement • April 30th, 2019 • Midatech Pharma PLC • Pharmaceutical preparations • England
CONFIDENTIAL TREATMENT REQUESTED: Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (“[***]”) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.
LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENTLicense, Collaboration and Distribution Agreement • November 7th, 2017 • New York
